Allena Pharmaceuticals, Inc. Inventory Turnover

Inventory Turnover of ALNA for past 10 years: annual, quarterly and twelve month trailing (TTM) including Inventory Turnover growth rates and interactive chart.


Highlights and Quick Summary

  • Annual Inventory Turnover for 2021 was 0.0 (a NaN% decrease from previous year)
  • Annual Inventory Turnover for 2020 was 0.0 (a NaN% decrease from previous year)
  • Annual Inventory Turnover for 2019 was 0.0 (a NaN% decrease from previous year)
  • Twelve month Inventory Turnover ending December 31, 2021 was 0.0 (a NaN% decrease compared to previous quarter)
  • Twelve month trailing Inventory Turnover decreased by NaN% year-over-year
Trailing Inventory Turnover for the last four month:
31 Dec '21 30 Sep '21 30 Jun '21 31 Mar '21
0.0 0.0 0.0 0.0
Visit stockrow.com/ALNA for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Inventory Turnover of Allena Pharmaceuticals, Inc.

Most recent Inventory Turnoverof ALNA including historical data for past 10 years.

Interactive Chart of Inventory Turnover of Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc. Inventory Turnover for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 0.0
2020 0.0
2019 0.0
2018 0.0
2017 0.0
2016 0.0

Business Profile of Allena Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.